{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T06:26:03Z","timestamp":1778135163658,"version":"3.51.4"},"reference-count":7,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathology"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1097\/pat.0b013e32834e4203","type":"journal-article","created":{"date-parts":[[2011,12,13]],"date-time":"2011-12-13T01:03:54Z","timestamp":1323738234000},"page":"55-57","source":"Crossref","is-referenced-by-count":6,"title":["Establishment of a conversion factor for the Cepheid GeneXpert BCR-ABL Assay"],"prefix":"10.1016","volume":"44","author":[{"given":"Michelle","family":"McNiven","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Talaulikarfi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1097\/PAT.0b013e32834e4203_bib0005","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1182\/blood-2006-01-0092","article-title":"Monitoring CML patients responding to treatment with tyrosine kinase inhibitors: review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results","volume":"108","author":"Hughes","year":"2006","journal-title":"Blood"},{"key":"10.1097\/PAT.0b013e32834e4203_bib0010","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1038\/sj.leu.2404388","article-title":"Rationale for the recommendations for harmonizing current methodology for detecting BCR-ABL transcripts in patients with chronic myeloid leukaemia","volume":"20","author":"Branford","year":"2006","journal-title":"Leukaemia"},{"key":"10.1097\/PAT.0b013e32834e4203_bib0015","doi-asserted-by":"crossref","first-page":"e111","DOI":"10.1182\/blood-2010-06-291641","article-title":"Establishment of the first World Health Organisation International Genetic Reference Panel for quantitation of BCR-ABL mRNA","volume":"116","author":"White","year":"2010","journal-title":"Blood"},{"key":"10.1097\/PAT.0b013e32834e4203_bib0020","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1080\/00313020801916172","article-title":"Current and emerging tests for the laboratory monitoring of chronic myeloid leukaemia and related disorders","volume":"40","author":"Ross","year":"2008","journal-title":"Pathology"},{"key":"10.1097\/PAT.0b013e32834e4203_bib0025","doi-asserted-by":"crossref","first-page":"970","DOI":"10.3324\/haematol.11172","article-title":"An international study to standardize the detection and quantitation of BCR-ABL transcripts from stabilized peripheral blood preparations by quantitative RT-PCR","volume":"92","author":"Muller","year":"2007","journal-title":"Haematologica"},{"key":"10.1097\/PAT.0b013e32834e4203_bib0030","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.1182\/blood-2008-04-150680","article-title":"Desirable performance characteristics for BCR-ABL measurement on an international reporting scale to allow consistent interpretation of individual patient response and comparison of response rates between clinical trials","volume":"112","author":"Branford","year":"2008","journal-title":"Blood"},{"key":"10.1097\/PAT.0b013e32834e4203_bib0035","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0140-6736(86)90837-8","article-title":"Statistical methods for assessing agreement between two methods of clinical measurement","volume":"1","author":"Bland","year":"1986","journal-title":"Lancet"}],"container-title":["Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302516326010?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302516326010?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,27]],"date-time":"2018-11-27T21:24:11Z","timestamp":1543353851000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031302516326010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":7,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S0031302516326010"],"URL":"https:\/\/doi.org\/10.1097\/pat.0b013e32834e4203","relation":{},"ISSN":["0031-3025"],"issn-type":[{"value":"0031-3025","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}